Join leading biopharmaceutical and biotechnology executives, patient advocacy groups, community-based lived experience rare disease professionals, government and regulatory authorities, investors and seasoned solution providers in discussing current trends, evolutionary innovations, best practices, strategic business models, real-world solutions, m
26-29 June 2023